Free Submission Public Relations &
Deutsch English


"Agile Therapeutics, Inc. - Product Pipeline Review - 2012" Published

Print article Print article
2013-01-28 07:11:06 - Fast Market Research recommends "Agile Therapeutics, Inc. - Product Pipeline Review - 2012" from Global Markets Direct, now available

Global Market Direct's pharmaceuticals report, "Agile Therapeutics, Inc. - Product Pipeline Review - 2012" provides data on the Agile Therapeutics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Agile Therapeutics, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Agile Therapeutics, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at
- ..


* Agile Therapeutics, Inc. - Brief Agile Therapeutics, Inc. overview including business description, key

information and facts, and its locations and subsidiaries.
* Review of current pipeline of Agile Therapeutics, Inc. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Agile Therapeutics, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Agile Therapeutics, Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to buy

* Evaluate Agile Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Agile Therapeutics, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Agile Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Agile Therapeutics, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Agile Therapeutics, Inc. and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Agile Therapeutics, Inc. Snapshot
Agile Therapeutics, Inc. Overview
Key Information
Key Facts
Agile Therapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
Agile Therapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Agile Therapeutics, Inc. - Pipeline Products Glance
Agile Therapeutics, Inc. - Late Stage Pipeline
Registration Filed Products/Combination Treatment Modalities
Agile Therapeutics, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Agile Therapeutics, Inc. - Drug Profiles
(ethinyl estradiol + levonorgestrel)
Product Description
Mechanism of Action
R&D Progress
Contraceptive Patch Program
Product Description
Mechanism of Action
R&D Progress
Product Description
Mechanism of Action
R&D Progress
Agile Therapeutics, Inc. - Pipeline Products by Route of Administration
Agile Therapeutics, Inc. - Pipeline Products By Mechanism of Action
Agile Therapeutics, Inc. - Recent Pipeline Updates
Agile Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Agile Therapeutics, Inc., Recent Developments
Agile Therapeutics, Inc.- Press Release
Nov 01, 2012: Agile Therapeutics Presents Positive Phase III Pivotal Trial Data Of AG200-15 Contraceptive Patch
Sep 24, 2012: Agile Therapeutics' Contraceptive Patch Exhibit Greater Compliance Than Oral Contraceptive In Phase III Study
Sep 20, 2012: Agile Therapeutics To Present At CBI's Forum On Phase II-III Clinical Study Optimization
Aug 27, 2012: Agile Therapeutics Announces Three New US Patents For Contraceptive Patch Technology And Brand Name Twirla For First Contraceptive Patch
Jul 03, 2012: Agile Therapeutics Announces FDA Accepts New Drug Application For Low-Dose, Once-Weekly Contraceptive Patch
Jun 21, 2012: Agile Therapeutics To Provide Update On AG200-15 At Biotechnology Industry Organization International Convention
May 07, 2012: Agile Announces Results From Phase III Pivotal AG200-15 Trial
Apr 25, 2012: Agile Therapeutics To Present New Studies On Low-Dose Contraceptive Patch At The College's Annual Clinical Meeting
Mar 29, 2012: Agile Provides Insights On Commercialization Plans Of AG200-15 Contraceptive Patch
Jan 02, 2012: Agile Announces Completion Of AG200-15 Phase III Clinical Program
Financial Deals Landscape
Agile Therapeutics, Inc., Deals Summary
Agile Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Agile Therapeutics Raises $40 Million In Series C Financing
Agile Therapeutics Secures Additional $22 Million In Series B Preferred Stock Financing Round
Agile Therapeutics Secures $1 Million In Venture Financing
Agile Therapeutics Secures $17.6 Million In Series E Financing
Agile Therapeutics Secures $12 Million In Venture Financing
Secondary Research
Primary Research
Expert Panel Validation
Contact Us

List of Tables
Agile Therapeutics, Inc., Key Information

Full Table of Contents is available at:

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact | BidVertiser